Graphy unveils Tera Harz Wide Cure and SMA Portal at AAO 2026, targets North American aligner market

Graphy, the South Korean company that commercialized the world’s first direct 3D printed shape memory aligner (SMA), used the American Association of Orthodontists Annual Session (AAO 2026) in early May to launch two key products aimed at the North American market. The company unveiled the Tera Harz Wide Cure, a large-format nitrogen curing system capable of processing up to 30 SMA aligners simultaneously — a 3.7x throughput improvement over its predecessor — alongside the SMA Portal, an AI-driven digital orthodontic platform that integrates ordering, design, 3D printing, and final aligner fabrication into a single workflow. Graphy also hosted lectures from leading orthodontic academics to support clinical validation in the region.

This expansion targets the largest single market for clear aligner therapy, where Align Technology’s Invisalign brand has long dominated using vat photopolymerization (VPP) for mass production. Graphy’s direct 3D printing approach — bypassing the traditional thermoforming step — offers a fundamentally different value proposition: shape memory materials that can reduce the number of aligners per case and enable in-house or lab-based production with lower capital investment. The Tera Harz Wide Cure’s 30-unit batch capacity and nine-level cure control directly address the throughput and standardization requirements of North American dental labs and large orthodontic practices. The SMA Portal platform further reduces friction by digitizing the entire workflow, a critical enabler for clinics that want to move away from centralized aligner supply chains.

Graphy’s move is a calculated bet on workflow integration rather than just material performance. The company must now prove it can match the reliability and clinical evidence base that Align has built over two decades, while convincing orthodontists that a direct-print workflow delivers consistent results at scale. For the North American market, the immediate test will be whether Graphy can secure partnerships with major dental lab networks and build a service infrastructure that matches the speed and quality of the incumbent thermoforming model. The technology is compelling; the execution challenge is now the story.